| Document Date: 2006-08-18 07:54:01
Open Document File Size: 678,00 KBShare Result on Facebook
City Geneva / / Continent Europe / / Country Switzerland / Netherlands / Saudi Arabia / Italy / France / Japan / United States / Canada / Portugal / United Kingdom / Spain / Ireland / / / Event Product Issues / Product Recall / / / IndustryTerm blood products / biological and pharmaceutical products / human food chain / medicinal products / food / pharmaceuticals / beef products / surveillance systems / medicinal product / pharmaceutical and biological products / pharmaceutical products / / MedicalCondition Gerstmann-Sträussler-Scheinker syndrome / myoclonus / epidemic / sporadic CJD / iatrogenic CJD / fatal brain disease / prion disease / BSE epidemic / Encephalopathy / infectious agent / Familial CJD / both diseases / infectious agents / neurodegenerative disorders / ataxia / sporadic disease / variant Creutzfeldt-Jakob disease / scrapie BSE / Creutzfeldt-Jakob disease / transfusion-transmitted vCJD infections / vCJD Scrapie / Creutzfeldt-Jakob syndrome / disease / transmitted disease / bovine spongiform encephalopathy agent / fatal familial insomnia / CJD / vCJD infections / natural scrapie / transfusion-transmitted infections / transmissible spongiform encephalopathies / scrapie / muscles and peripheral nervous system cjd / transmissible spongiform encephalopathy / diseases / variant CJD / animal Transmissible Spongiform Encephalopathies / rapidly progressive dementia / infection / Bovine spongiform encephalopathy / human disease / / MedicalTreatment Blood transfusion / blood transfusions / corneal transplants / / Organization World Health Organization / Plasma Derivatives and Related Substances Department of Medicines Policy and Standards Health Technology / / Person Transmissible Spongiform Encephalopathies / Paul Brown / / / Position France CONTENTS EXECUTIVE / EXECUTIVE / / Product market / human-pituitary-derived growth hormone / / Technology Recombinant DNA / / URL http /
SocialTag |
WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies